These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8935178)

  • 21. Chronic dapsone use causing methemoglobinemia with oxidative hemolysis and dyserythropoiesis.
    Gallardo CA; Fan BE; Lim KGE; Kuperan P
    Am J Hematol; 2021 Dec; 96(12):1715-1716. PubMed ID: 33524190
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lip cyanosis in dapsone therapy: should the dosage be reduced?].
    Stichtenoth D
    MMW Fortschr Med; 2012 Apr; 154(6):32. PubMed ID: 22642026
    [No Abstract]   [Full Text] [Related]  

  • 23. [Respiratory insufficiency caused by dapsone-induced methemoglobinemia].
    Ipsen SE; Hansen VE
    Ugeskr Laeger; 2001 Jan; 163(1):39-40. PubMed ID: 11586671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapsone as treatment adjunct in ARDS.
    Kast RE
    Exp Lung Res; 2020; 46(5):157-161. PubMed ID: 32286085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dapsone-associated methaemoglobinaemia in patients with a haematologic malignancy.
    Subramaniam A; Corallo C; Nagappan R
    Anaesth Intensive Care; 2010 Nov; 38(6):1070-6. PubMed ID: 21226440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents.
    Speeg KV; Patwardhan RV; Avant GR; Mitchell MC; Schenker S
    Gastroenterology; 1982 Jan; 82(1):89-96. PubMed ID: 6118315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hematologic effects of dapsone (Disulone)].
    Bordessoule D; Liozon E; Cransac M; Bonnetblanc JM; Vidal E; Weinbreck P; Liozon F
    Rev Med Interne; 1989; 10(6):531-6. PubMed ID: 2488504
    [No Abstract]   [Full Text] [Related]  

  • 29. Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant.
    Talarico JF; Metro DG
    J Clin Anesth; 2005 Nov; 17(7):568-70. PubMed ID: 16297761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency.
    Pirmohamed M; Williams D; Tingle MD; Barry M; Khoo SH; O'Mahony C; Wilkins EG; Breckenridge AM; Park BK
    AIDS; 1996 May; 10(5):501-7. PubMed ID: 8724041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of dapsone-induced methaemoglobinaemia.
    Tan YA; Ng KC; Cheo SW; Khoo TT; Low QJ
    Clin Med (Lond); 2020 Sep; 20(5):519-521. PubMed ID: 32934050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex.
    Levine M; Bellward GD
    Drug Metab Dispos; 1995 Dec; 23(12):1407-11. PubMed ID: 8689952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
    Coleman MD; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
    Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
    J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subtle case of dapsone-induced methaemoglobinaemia.
    Lewis JS; Jacobs ZG
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dapsone-Induced Hemolytic Anemia in Multiple Myeloma: Case Report of Various Differential Diagnoses.
    Rassner M; Jung J; Schneider J; Wäsch R; Engelhardt M
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e821-e825. PubMed ID: 32753123
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-induced methaemoglobinaemia. Treatment issues.
    Coleman MD; Coleman NA
    Drug Saf; 1996 Jun; 14(6):394-405. PubMed ID: 8828017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of dapsone-induced methaemoglobinaemia in the rat.
    Coleman MD; Winn MJ; Breckenridge AM; Park BK
    Biochem Pharmacol; 1990 Feb; 39(4):802-5. PubMed ID: 2306285
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of dapsone poisoning complicated by methaemoglobinaemia.
    Dawson AH; Whyte IM
    Med Toxicol Adverse Drug Exp; 1989; 4(5):387-92. PubMed ID: 2811676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450-dependent toxicity of dapsone in human erythrocytes.
    Ganesan S; Sahu R; Walker LA; Tekwani BL
    J Appl Toxicol; 2010 Apr; 30(3):271-5. PubMed ID: 19998329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.